{"id":456,"date":"2013-12-05T16:17:00","date_gmt":"2013-12-05T15:17:00","guid":{"rendered":"https:\/\/academia-eng.com\/?p=456"},"modified":"2023-10-21T16:27:34","modified_gmt":"2023-10-21T14:27:34","slug":"gestione-dellintegrita-degli-asset-nelle-organizzazioni-farmaceutiche","status":"publish","type":"post","link":"https:\/\/academia-eng.com\/en\/2013\/12\/gestione-dellintegrita-degli-asset-nelle-organizzazioni-farmaceutiche\/","title":{"rendered":"Asset Integrity Management in Pharmaceutical Organizations"},"content":{"rendered":"<p class=\"translation-block\">This document is a resource for pharmaceutical organizations aiming to ensure the integrity and efficiency of their assets. The document, drawn up for <a href=\"https:\/\/ispe.org\/italy-affiliate\" target=\"_blank\" rel=\"noreferrer noopener\">ISPE<\/a>, offers a detailed overview of the fundamental principles of asset integrity and best practices in the pharmaceutical industry.<\/p>\n\n\n\n<!--more-->\n\n\n\n<p>Here is a summary of the key points:<\/p>\n\n\n\n<p><strong>1. Regulatory Context:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Illustrates the mandatory and voluntary rules that govern asset management.<\/li>\n\n\n\n<li>Introduces the concepts of standards, best practices and technical specifications, explaining the differences between them.<\/li>\n<\/ul>\n\n\n\n<p><strong>2. The Stakeholders:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Explains who the stakeholders are and their role in developing standards at national and organizational levels.<\/li>\n<\/ul>\n\n\n\n<p><strong>3. Definition of Asset:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>It presents a broad definition of assets, including tangible and intangible resources.<\/li>\n\n\n\n<li>Lists the benefits of effective Asset Integrity Management, including financial improvement, risk management and improved corporate reputation.<\/li>\n<\/ul>\n\n\n\n<p><strong>4. Philosophy and Procedures:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Describes the process of developing a maintenance program for pharmaceutical facilities, taking into account cGMP requirements and other drivers such as health and safety, environmental protection and business continuity.<\/li>\n\n\n\n<li>Introduces \u201cBase Practices,\u201d \u201cGood Practices\u201d and \u201cBest Practices\u201d in maintenance, illustrating how to meet cGMP requirements.<\/li>\n<\/ul>\n\n\n\n<p><strong>5. Quality Risk Management:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Highlights the importance of risk analysis in asset management.<\/li>\n\n\n\n<li>Introduces tools such as RCM Analysis, FMEA and RCFA to evaluate and mitigate risks associated with maintenance activities.<\/li>\n<\/ul>\n\n\n\n<p><strong>6. Training and Certification:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Emphasizes the importance of training personnel involved in the operations and maintenance of assets.<\/li>\n\n\n\n<li>Introduces training methods, such as prepared questions, simulation exercises and demonstrations of on-the-job skills.<\/li>\n<\/ul>\n\n\n\n<p>Download the full PDF to explore these concepts in depth and implement best practices in your organization.<\/p>\n\n\n\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-container-core-buttons-is-layout-16018d1d wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/academia-eng.com\/wp-content\/uploads\/2023\/10\/Come-nasce-una-norma_Rolandi_ISPE-2013.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Download the PDF document (in Italian)<\/a><\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Questo documento \u00e8 una risorsa per le organizzazioni farmaceutiche che mirano a garantire l&#8217;integrit\u00e0 e l&#8217;efficienza dei loro asset. Il documento, redatto per ISPE, offre&hellip;<\/p>","protected":false},"author":3,"featured_media":457,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[19],"tags":[32,31],"class_list":["post-456","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-guide","tag-farmaceutica","tag-guide"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Integrit\u00e0 degli Asset nelle Organizzazioni Farmaceutiche - Academia s.a.s.<\/title>\n<meta name=\"description\" content=\"Questo documento \u00e8 una risorsa per le organizzazioni farmaceutiche che mirano a garantire l&#039;integrit\u00e0 e l&#039;efficienza dei loro asset.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/academia-eng.com\/en\/2013\/12\/gestione-dellintegrita-degli-asset-nelle-organizzazioni-farmaceutiche\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Integrit\u00e0 degli Asset nelle Organizzazioni Farmaceutiche - Academia s.a.s.\" \/>\n<meta property=\"og:description\" content=\"Questo documento \u00e8 una risorsa per le organizzazioni farmaceutiche che mirano a garantire l&#039;integrit\u00e0 e l&#039;efficienza dei loro asset.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/academia-eng.com\/en\/2013\/12\/gestione-dellintegrita-degli-asset-nelle-organizzazioni-farmaceutiche\/\" \/>\n<meta property=\"og:site_name\" content=\"Academia s.a.s.\" \/>\n<meta property=\"article:published_time\" content=\"2013-12-05T15:17:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-21T14:27:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/academia-eng.com\/wp-content\/uploads\/2023\/10\/ISPE.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"960\" \/>\n\t<meta property=\"og:image:height\" content=\"576\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Claudio Rolandi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Claudio Rolandi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/academia-eng.com\\\/2013\\\/12\\\/gestione-dellintegrita-degli-asset-nelle-organizzazioni-farmaceutiche\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/academia-eng.com\\\/2013\\\/12\\\/gestione-dellintegrita-degli-asset-nelle-organizzazioni-farmaceutiche\\\/\"},\"author\":{\"name\":\"Claudio Rolandi\",\"@id\":\"https:\\\/\\\/academia-eng.com\\\/#\\\/schema\\\/person\\\/2c13a207eebe49ac2ae95e23f44b1beb\"},\"headline\":\"Gestione dell&#8217;integrit\u00e0 degli asset nelle organizzazioni farmaceutiche\",\"datePublished\":\"2013-12-05T15:17:00+00:00\",\"dateModified\":\"2023-10-21T14:27:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/academia-eng.com\\\/2013\\\/12\\\/gestione-dellintegrita-degli-asset-nelle-organizzazioni-farmaceutiche\\\/\"},\"wordCount\":276,\"publisher\":{\"@id\":\"https:\\\/\\\/academia-eng.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/academia-eng.com\\\/2013\\\/12\\\/gestione-dellintegrita-degli-asset-nelle-organizzazioni-farmaceutiche\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/academia-eng.com\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/ISPE.jpg\",\"keywords\":[\"Farmaceutica\",\"Guide\"],\"articleSection\":[\"Guide\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/academia-eng.com\\\/2013\\\/12\\\/gestione-dellintegrita-degli-asset-nelle-organizzazioni-farmaceutiche\\\/\",\"url\":\"https:\\\/\\\/academia-eng.com\\\/2013\\\/12\\\/gestione-dellintegrita-degli-asset-nelle-organizzazioni-farmaceutiche\\\/\",\"name\":\"Integrit\u00e0 degli Asset nelle Organizzazioni Farmaceutiche - Academia s.a.s.\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/academia-eng.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/academia-eng.com\\\/2013\\\/12\\\/gestione-dellintegrita-degli-asset-nelle-organizzazioni-farmaceutiche\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/academia-eng.com\\\/2013\\\/12\\\/gestione-dellintegrita-degli-asset-nelle-organizzazioni-farmaceutiche\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/academia-eng.com\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/ISPE.jpg\",\"datePublished\":\"2013-12-05T15:17:00+00:00\",\"dateModified\":\"2023-10-21T14:27:34+00:00\",\"description\":\"Questo documento \u00e8 una risorsa per le organizzazioni farmaceutiche che mirano a garantire l'integrit\u00e0 e l'efficienza dei loro asset.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/academia-eng.com\\\/2013\\\/12\\\/gestione-dellintegrita-degli-asset-nelle-organizzazioni-farmaceutiche\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/academia-eng.com\\\/2013\\\/12\\\/gestione-dellintegrita-degli-asset-nelle-organizzazioni-farmaceutiche\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/academia-eng.com\\\/2013\\\/12\\\/gestione-dellintegrita-degli-asset-nelle-organizzazioni-farmaceutiche\\\/#primaryimage\",\"url\":\"https:\\\/\\\/academia-eng.com\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/ISPE.jpg\",\"contentUrl\":\"https:\\\/\\\/academia-eng.com\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/ISPE.jpg\",\"width\":960,\"height\":576,\"caption\":\"IPSE\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/academia-eng.com\\\/2013\\\/12\\\/gestione-dellintegrita-degli-asset-nelle-organizzazioni-farmaceutiche\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/academia-eng.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gestione dell&#8217;integrit\u00e0 degli asset nelle organizzazioni farmaceutiche\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/academia-eng.com\\\/#website\",\"url\":\"https:\\\/\\\/academia-eng.com\\\/\",\"name\":\"Academia s.a.s.\",\"description\":\"Engineering Consultants\",\"publisher\":{\"@id\":\"https:\\\/\\\/academia-eng.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/academia-eng.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/academia-eng.com\\\/#organization\",\"name\":\"ACADEMIA s.a.s. di Rolandi Claudio & C.\",\"url\":\"https:\\\/\\\/academia-eng.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/academia-eng.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/academia-eng.com\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/Logo-New-Academia-A.png\",\"contentUrl\":\"https:\\\/\\\/academia-eng.com\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/Logo-New-Academia-A.png\",\"width\":1031,\"height\":961,\"caption\":\"ACADEMIA s.a.s. di Rolandi Claudio & C.\"},\"image\":{\"@id\":\"https:\\\/\\\/academia-eng.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/in\\\/claudio-rolandi-9a449012\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/academia-eng.com\\\/#\\\/schema\\\/person\\\/2c13a207eebe49ac2ae95e23f44b1beb\",\"name\":\"Claudio Rolandi\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/academia-eng.com\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/cropped-Rolandi-Claudio-1-96x96.webp\",\"url\":\"https:\\\/\\\/academia-eng.com\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/cropped-Rolandi-Claudio-1-96x96.webp\",\"contentUrl\":\"https:\\\/\\\/academia-eng.com\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/cropped-Rolandi-Claudio-1-96x96.webp\",\"caption\":\"Claudio Rolandi\"},\"sameAs\":[\"https:\\\/\\\/academia-eng.com\\\/\"],\"url\":\"https:\\\/\\\/academia-eng.com\\\/en\\\/author\\\/c-rolandi\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Integrit\u00e0 degli Asset nelle Organizzazioni Farmaceutiche - Academia s.a.s.","description":"Questo documento \u00e8 una risorsa per le organizzazioni farmaceutiche che mirano a garantire l'integrit\u00e0 e l'efficienza dei loro asset.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/academia-eng.com\/en\/2013\/12\/gestione-dellintegrita-degli-asset-nelle-organizzazioni-farmaceutiche\/","og_locale":"en_US","og_type":"article","og_title":"Integrit\u00e0 degli Asset nelle Organizzazioni Farmaceutiche - Academia s.a.s.","og_description":"Questo documento \u00e8 una risorsa per le organizzazioni farmaceutiche che mirano a garantire l'integrit\u00e0 e l'efficienza dei loro asset.","og_url":"https:\/\/academia-eng.com\/en\/2013\/12\/gestione-dellintegrita-degli-asset-nelle-organizzazioni-farmaceutiche\/","og_site_name":"Academia s.a.s.","article_published_time":"2013-12-05T15:17:00+00:00","article_modified_time":"2023-10-21T14:27:34+00:00","og_image":[{"width":960,"height":576,"url":"https:\/\/academia-eng.com\/wp-content\/uploads\/2023\/10\/ISPE.jpg","type":"image\/jpeg"}],"author":"Claudio Rolandi","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Claudio Rolandi","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/academia-eng.com\/2013\/12\/gestione-dellintegrita-degli-asset-nelle-organizzazioni-farmaceutiche\/#article","isPartOf":{"@id":"https:\/\/academia-eng.com\/2013\/12\/gestione-dellintegrita-degli-asset-nelle-organizzazioni-farmaceutiche\/"},"author":{"name":"Claudio Rolandi","@id":"https:\/\/academia-eng.com\/#\/schema\/person\/2c13a207eebe49ac2ae95e23f44b1beb"},"headline":"Gestione dell&#8217;integrit\u00e0 degli asset nelle organizzazioni farmaceutiche","datePublished":"2013-12-05T15:17:00+00:00","dateModified":"2023-10-21T14:27:34+00:00","mainEntityOfPage":{"@id":"https:\/\/academia-eng.com\/2013\/12\/gestione-dellintegrita-degli-asset-nelle-organizzazioni-farmaceutiche\/"},"wordCount":276,"publisher":{"@id":"https:\/\/academia-eng.com\/#organization"},"image":{"@id":"https:\/\/academia-eng.com\/2013\/12\/gestione-dellintegrita-degli-asset-nelle-organizzazioni-farmaceutiche\/#primaryimage"},"thumbnailUrl":"https:\/\/academia-eng.com\/wp-content\/uploads\/2023\/10\/ISPE.jpg","keywords":["Farmaceutica","Guide"],"articleSection":["Guide"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/academia-eng.com\/2013\/12\/gestione-dellintegrita-degli-asset-nelle-organizzazioni-farmaceutiche\/","url":"https:\/\/academia-eng.com\/2013\/12\/gestione-dellintegrita-degli-asset-nelle-organizzazioni-farmaceutiche\/","name":"Integrit\u00e0 degli Asset nelle Organizzazioni Farmaceutiche - Academia s.a.s.","isPartOf":{"@id":"https:\/\/academia-eng.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/academia-eng.com\/2013\/12\/gestione-dellintegrita-degli-asset-nelle-organizzazioni-farmaceutiche\/#primaryimage"},"image":{"@id":"https:\/\/academia-eng.com\/2013\/12\/gestione-dellintegrita-degli-asset-nelle-organizzazioni-farmaceutiche\/#primaryimage"},"thumbnailUrl":"https:\/\/academia-eng.com\/wp-content\/uploads\/2023\/10\/ISPE.jpg","datePublished":"2013-12-05T15:17:00+00:00","dateModified":"2023-10-21T14:27:34+00:00","description":"Questo documento \u00e8 una risorsa per le organizzazioni farmaceutiche che mirano a garantire l'integrit\u00e0 e l'efficienza dei loro asset.","breadcrumb":{"@id":"https:\/\/academia-eng.com\/2013\/12\/gestione-dellintegrita-degli-asset-nelle-organizzazioni-farmaceutiche\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/academia-eng.com\/2013\/12\/gestione-dellintegrita-degli-asset-nelle-organizzazioni-farmaceutiche\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/academia-eng.com\/2013\/12\/gestione-dellintegrita-degli-asset-nelle-organizzazioni-farmaceutiche\/#primaryimage","url":"https:\/\/academia-eng.com\/wp-content\/uploads\/2023\/10\/ISPE.jpg","contentUrl":"https:\/\/academia-eng.com\/wp-content\/uploads\/2023\/10\/ISPE.jpg","width":960,"height":576,"caption":"IPSE"},{"@type":"BreadcrumbList","@id":"https:\/\/academia-eng.com\/2013\/12\/gestione-dellintegrita-degli-asset-nelle-organizzazioni-farmaceutiche\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/academia-eng.com\/"},{"@type":"ListItem","position":2,"name":"Gestione dell&#8217;integrit\u00e0 degli asset nelle organizzazioni farmaceutiche"}]},{"@type":"WebSite","@id":"https:\/\/academia-eng.com\/#website","url":"https:\/\/academia-eng.com\/","name":"Academia s.a.s.","description":"Engineering Consultants","publisher":{"@id":"https:\/\/academia-eng.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/academia-eng.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/academia-eng.com\/#organization","name":"ACADEMIA s.a.s. di Rolandi Claudio & C.","url":"https:\/\/academia-eng.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/academia-eng.com\/#\/schema\/logo\/image\/","url":"https:\/\/academia-eng.com\/wp-content\/uploads\/2023\/09\/Logo-New-Academia-A.png","contentUrl":"https:\/\/academia-eng.com\/wp-content\/uploads\/2023\/09\/Logo-New-Academia-A.png","width":1031,"height":961,"caption":"ACADEMIA s.a.s. di Rolandi Claudio & C."},"image":{"@id":"https:\/\/academia-eng.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/in\/claudio-rolandi-9a449012\/"]},{"@type":"Person","@id":"https:\/\/academia-eng.com\/#\/schema\/person\/2c13a207eebe49ac2ae95e23f44b1beb","name":"Claudio Rolandi","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/academia-eng.com\/wp-content\/uploads\/2023\/10\/cropped-Rolandi-Claudio-1-96x96.webp","url":"https:\/\/academia-eng.com\/wp-content\/uploads\/2023\/10\/cropped-Rolandi-Claudio-1-96x96.webp","contentUrl":"https:\/\/academia-eng.com\/wp-content\/uploads\/2023\/10\/cropped-Rolandi-Claudio-1-96x96.webp","caption":"Claudio Rolandi"},"sameAs":["https:\/\/academia-eng.com\/"],"url":"https:\/\/academia-eng.com\/en\/author\/c-rolandi\/"}]}},"author_meta":{"display_name":"Claudio Rolandi","author_link":"https:\/\/academia-eng.com\/en\/author\/c-rolandi\/"},"featured_img":"https:\/\/academia-eng.com\/wp-content\/uploads\/2023\/10\/ISPE-300x180.jpg","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/academia-eng.com\/en\/category\/guide\/\" class=\"advgb-post-tax-term\">Guide<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Guide<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/academia-eng.com\/en\/category\/guide\/\" class=\"advgb-post-tax-term\">Farmaceutica<\/a>","<a href=\"https:\/\/academia-eng.com\/en\/category\/guide\/\" class=\"advgb-post-tax-term\">Guide<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Farmaceutica<\/span>","<span class=\"advgb-post-tax-term\">Guide<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 12 years ago","modified":"Updated 3 years ago"},"absolute_dates":{"created":"Posted on 5 December 2013","modified":"Updated on 21 October 2023"},"absolute_dates_time":{"created":"Posted on 5 December 2013 16:17","modified":"Updated on 21 October 2023 16:27"},"featured_img_caption":"","series_order":"","_links":{"self":[{"href":"https:\/\/academia-eng.com\/en\/wp-json\/wp\/v2\/posts\/456","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/academia-eng.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/academia-eng.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/academia-eng.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/academia-eng.com\/en\/wp-json\/wp\/v2\/comments?post=456"}],"version-history":[{"count":7,"href":"https:\/\/academia-eng.com\/en\/wp-json\/wp\/v2\/posts\/456\/revisions"}],"predecessor-version":[{"id":467,"href":"https:\/\/academia-eng.com\/en\/wp-json\/wp\/v2\/posts\/456\/revisions\/467"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/academia-eng.com\/en\/wp-json\/wp\/v2\/media\/457"}],"wp:attachment":[{"href":"https:\/\/academia-eng.com\/en\/wp-json\/wp\/v2\/media?parent=456"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/academia-eng.com\/en\/wp-json\/wp\/v2\/categories?post=456"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/academia-eng.com\/en\/wp-json\/wp\/v2\/tags?post=456"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}